Abstract:Introduction: Newer research has highlighted significant neurological impairments in children and adults with congenital heart disease (CHD). The more severe the heart defect, the higher the neurologic impairment. Pregnancies complicated by fetal or maternal CHD carry a higher risk of placental abnormalities. We studied the association between pregnancy hormonal levels and fetal head and body growth. Hypothesis: Placental dysfunction in pregnancies with fetal or maternal CHD alters pregnancy hormonal levels affecting fetal brain and somatic growth. Methods: We performed a retrospective case-control study on pregnant women (year 2010-2019) at the University of Iowa. Only women with first and/or second trimester prenatal screening (ultrasound and blood test) were included. Pregnancies with fetal chromosomal abnormalities, multiple gestation, maternal diabetes, smoking, or hypertension were excluded. Pregnancies were either healthy controls (n=36), women with CHD (MCHD; n=26), or fetus with CHD (FCHD; n=23). Pregnancy hormonal levels, ultrasound findings, and fetal/neonatal growth percentiles and/or z-scores data were analyzed. Results: Women with CHD were younger (p=0.004) with increased fetal nuchal translucency (p=0.003) compared to controls. Women in MCHD (p=0.02) and FCHD (p=0.02) group delivered earlier than controls. FCHD had significantly lower pregnancy associated plasma protein-A (PAPP-A) levels than controls (p=0.04). The groups had no difference in the second trimester fetal head circumference (HC) and femur length. FCHD group had significantly smaller HC percentile (p=0.03) and z-scores (p=0.03) at birth than controls. Both FCHD and MCHD had smaller birth weight and length compared to controls. However, only FCHD group demonstrated significantly lower HC to birth weight ratio (p=0.01). The controls had a positive correlation between human chorionic gonadotropin level and head circumference z-score at birth (r=0.34;p=0.053). Conclusions: Pregnant women with CHD have increased fetal nuchal translucency and deliver at earlier gestational age. Women with fetal CHD have smaller neonatal head and body size at birth with associated low PAPP-A level early in their pregnancy probably related to placental dysfunction.

EP18.20: Association of chromosomal abnormalities and cardiac defects with increased nuchal translucency and/or tricuspid regurgitation in South Indian population

EP18.28: Association of chromosomal abnormalities and cardiac defects with increased nuchal translucency and/or ductus venosus PI>1.3 in South Indian population

EP18.31: Impact of increased nuchal translucency values on pregnancy outcomes

EP18.32: Increased nuchal translucency and cystic hygroma: pregnancy outcomes

EP18.10: Isolated unossified nasal bone in the first trimester: does it really improve Trisomy 21 detection? Experiences from Southern India

EP05.36: Association of prenatal conatal cysts with structural and genetic anomalies

EP18.13: Can combining second trimester quadruple test with mid‐trimester anomaly scan for soft markers and defects improve detection of chromosomal anomalies?

EP18.46: Kabuki‐Syndrome in a fetus with thickened nuchal translucency and congenital corrected transposition of the great arteries

Fetal Heart Rate Patterns and Umbilical Artery Flow Velocity Waveforms in Pregnancies with Trisomy 21

EP09.59: Fetal aberrant right subclavian artery: insights into association with additional soft markers, structural and chromosomal anomalies

Associations between genomic aberrations, increased nuchal translucency, and pregnancy outcomes: a comprehensive analysis of 2,272 singleton pregnancies in women under 35

EP07.03: Early insights: unravelling unique Trisomy 18 patterns in 11–14 week scans

Measurement of Nuchal Translucency Thickness for Detection of Chromosomal Abnormalities using First Trimester Ultrasound Fetal Images

Sonographic features of trisomy 18 at midpregnancy

A Chinese multicenter retrospective study of isolated increased nuchal translucency associated chromosome anomaly and prenatal diagnostic suggestions

EP07.70: Thickened nuchal translucency with a normal karyotype: management and prognosis

Abstract 16738: Association Between First and Second Trimester Maternal Screening Biochemistry, Ultrasound, and Fetal Brain Growth in Presence of Fetal or Maternal Congenital Heart Disease

EP06.66: Microtia and anotia have strong association with congenital heart diseases and IUGR

EP09.13: Congenital heart diseases unrecognised in the prenatal period: is the quality of obstetrical ultrasound related to the type of heart disease?

EP05.41: Alpha thalassemia major and malformation of cortical development: is it an incidental finding or truly related?

A rare case of trisomy 13 mosaicism with only findings on first-trimester ultrasound single umbilical artery and increased nuchal translucency